CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes

Diabetes Care - United States
doi 10.2337/dc15-2464
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Lack of Association Between Thiazolidinediones and Macular Edema in Type 2 Diabetes

Archives of Ophthalmology
2010English

Clinical Outcomes and Health Care Costs Combining Metformin With Sitagliptin or Sulphonylureas or Thiazolidinediones in Uncontrolled Type 2 Diabetes Patients

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2014English

Beta Cell Response to a Mixed Meal in Nigerian Patients With Type 2 Diabetes

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2012English

Mechanisms of Early Insulin-Sensitizing Effects of Thiazolidinediones in Type 2 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Different Glycaemic Patterns in Patients With Steroid Diabetes and Type 2 Diabetes

Endocrine Abstracts
2015English

Do Variants Associated With Susceptibility to Pancreatic Cancer and Type 2 Diabetes Reciprocally Affect Risk?

PLoS ONE
Multidisciplinary
2015English

Diet Quality and Therapeutic Targets in Patients With Type 2 Diabetes: Evaluation of Concordance Between Dietary Indexes

Nutrition Journal
MedicineNutritionDietetics
2017English

Metformin in Patients With Type 2 Diabetes and Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Malnutrition and Metabolic Changes in Patients With Type 2 Diabetes

Journal of Interdisciplinary Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy